Carregant...

Modern Obesity Pharmacotherapy: Weighing Cardiovascular Risk and Benefit

Obesity is a major correlate of cardiovascular disease. Weight loss improves cardiovascular risk factors and has the potential to improve outcomes. Two drugs, phentermine plus topiramate and lorcaserin, have recently been approved by the US Food and Drug Administration for the indication of obesity;...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cardiol
Autors principals: Cunningham, Jonathan W., Wiviott, Stephen D.
Format: Artigo
Idioma:Inglês
Publicat: Wiley Periodicals, Inc. 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6649490/
https://ncbi.nlm.nih.gov/pubmed/25223901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22304
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!